Translational medicine policy issues in infectious disease.
The European Academies Science Advisory Council has published a series of reports on infectious disease policy issues, analyzing priorities for building the science base as part of public health strategy. Among current challenges facing the European Union are the needs to tackle antibiotic resistance, promote vaccine innovation, prepare for the emergence of novel zoonoses, and integrate research approaches to human and animal health. The scientific community must help public policy-makers to address the organization, balance, and sustainability of research funding and infrastructure; encourage the creation of a more supportive regulatory environment for translational medicine; and evaluate new models for public-private partnership to facilitate innovation.
Fears
Robin
R
European Academies Science Advisory Council, The Royal Society, London SW1Y 5AG, UK. robinfears@aol.com
van der Meer
Jos W M
JW
ter Meulen
Volker
V
D000818:Animals; D000900:Anti-Bacterial Agents; D002986:Clinical Trials as Topic; D003140:Communicable Disease Control / Q000379:methods*; D003141:Communicable Diseases / Q000628:therapy*; D006291:Health Policy; D006801:Humans; D011640:Public Policy; D057170:Translational Research, Biomedical / Q000458:organization & administration* / Q000639:trends; D014612:Vaccines / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014612:Vaccines